NCT06491446 2026-02-18
Evaluating Clearance of High-Risk HPV and Safety After Administration of ABI-2280 Vaginal Inserts
Antiva Biosciences
Phase 1/2 Active not recruiting
Antiva Biosciences
Qurasense
University of Kansas Medical Center
Zydolab - Institute of Cytology and Immune Cytochemistry
Zhujiang Hospital